Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
RVX Resverlogix Corp
- 0.035
- -0.005-12.50%
15min DelayMarket Closed May 2 16:00 ET
9.82MMarket Cap-0.81P/E (TTM)
0.035High0.035Low4.56KVolume0.035Open0.040Pre Close159.00Turnover0.09552wk High0.00%Turnover Ratio280.65MShares0.03552wk Low-0.043EPS TTM6.67MFloat Cap29.500Historical HighLossP/E (Static)190.59MShs Float0.035Historical Low-0.043EPS LYR0.00%Amplitude--Dividend TTM-0.09P/B1Lot Size--Div YieldTTM
About Resverlogix Corp Company
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Company Profile
SymbolRVX
Company NameResverlogix Corp
Founded2000
MarketTSE
Employees18
Fiscal Year Ends12-31
Address4820 Richard Road South West Suite 300
CityCalgary
CountryCAN
Zip CodeT3E 6L1
Phone+1 403 254-9252
Websitehttps://www.resverlogix.com
Company Executives
- Name
- Position
- Salary
- Donald J. McCaffrey
- Chairman of the Board, President, Secretary and Chief Executive Officer
- --
- A. Brad Cann, C.A.,C.P.A.
- Chief Financial Officer
- --
- Dr. Ewelina Kulikowski, PhD
- Senior Vice President, Scientific Development and Chief Scientific Officer
- --
- Dr. Michael Sweeney,M.D.
- Senior Vice President, Clinical Development
- --
- Siu Lun To
- Independent Director
- --
- Kenneth J. Zuerblis
- Independent Director
- --
- Kelly McNeill, B.Comm.,C.A.
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting